Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene
Authors:
- 1 December 2005
- Vol. 70 (13) , 847-855
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK ActivationJournal of Biological Chemistry, 2001
- Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-αJournal of Clinical Investigation, 2000
- Characterization of osteoclast precursors in human bloodBritish Journal of Haematology, 2000
- The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Immunological Characterization of Circulating Osteoprotegerin/Osteoclastogenesis Inhibitory Factor: Increased Serum Concentrations in Postmenopausal Women with OsteoporosisJournal of Bone and Mineral Research, 1999
- Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosisJournal of Bone and Mineral Research, 1996
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.Journal of Clinical Investigation, 1994
- Electronic cell counting to measure total cell numbers in bronchoalveolar lavage fluidEuropean Respiratory Journal, 1994
- Analysis of serial measurements in medical research.BMJ, 1990